Press Release - Company Data

Osiris Therapeutics Announces Second Quarter 2014 Financial Results: Revenue Up 32% Over Previous Quarter
Posted 2014-08-07 00:09NAI Editing
the leading stem cell company focused on developing and marketing products in wound care, orthopedic and sports medicine markets announced today its financial results for the second quarter of 2014.

Osiris Therapeutics Announces Dwayne Montgomery as General Manager of Orthopedics and Sports Medicine
Posted 2014-04-25 00:00NAI Editing
the leading stem cell company focused on developing and marketing products to treat conditions in wound care, orthopedic and sports medicine markets, is pleased to announce the appointment of Dwayne M

Osiris Announces Receipt of $15 Million Cash Payment for Prochymal
Posted 2014-04-09 00:10NAI Editing
the leading stem cell company focused on developing and marketing products to treat conditions in wound care, orthopedic and sports medicine markets, announced that it has received the next $15 millio

Osiris Therapeutics Announces Therésa K. Dixon as General Manager of Market Access and Reimbursement
Posted 2014-03-25 23:41NAI Editing
the leading stem cell company focused on developing and marketing products to treat conditions in wound care, orthopedic and sports medicine markets, is pleased to announce the appointment of Therésa

Osiris Therapeutics Reports Change in Tax Benefit Allocation for Fourth Quarter and Full Year 2013 Financial Results
Posted 2014-03-10 23:49NAI Editing
announced today an accounting adjustment to its Fourth Quarter and Full Year 2013 financial results reported on March 5.

Osiris Therapeutics Reports Fourth Quarter and Full Year 2013 Financial Results: For the Full Year, Revenue Increased 3-Fold, Company was Profitable and Ended with Assets of $92.0 Million
Posted 2014-03-04 23:31NAI Editing
the leading stem cell company focused on developing and marketing products to treat conditions in wound care, orthopedic and sports medicine markets, announced today its results for the fourth quarter

Osiris Therapeutics Board Confirms Lode Debrabandere, PhD, MBA, as President and Chief Executive Officer
Posted 2014-01-13 23:32NAI Editing
the leading stem cell company focused on developing and marketing products to treat conditions in wound care, orthopedic and sports medicine markets is pleased to announce that its Board of Directors

Osiris Reports 3rd Quarter 2013 Results: Revenue Up 220%, Strong Balance Sheet, Profitable and Now Cash Flow Positive from Continuing Operations
Posted 2013-10-31 23:52NAI Editing
the leading stem cell company focused on developing and marketing products in orthopedic, sports medicine and wound care markets announced today its financial results for the third quarter of 2013.

Osiris Therapeutics Announces Second Quarter 2013 Financial Results
Posted 2013-08-04 22:52NAI Editing
the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets, announced today its result

Osiris Therapeutics Announces First Quarter 2013 Financial Results
Posted 2013-05-07 00:29NAI Editing
the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets, announced today its result